Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/Chemotherapy

por Möller, Miriam, Schütte, Wolfgang, Turzer, Steffi, Seliger, Barbara, Riemann, Dagmar
Publicado 2023

Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade

por Möller, Miriam, Turzer, Steffi, Schütte, Wolfgang, Seliger, Barbara, Riemann, Dagmar
Publicado 2020

High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy

por Riemann, Dagmar, Schütte, Wolfgang, Turzer, Steffi, Seliger, Barbara, Möller, Miriam
Publicado 2020

Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy

por Riemann, Dagmar, Turzer, Steffi, Ganchev, Georgi, Schütte, Wolfgang, Seliger, Barbara, Möller, Miriam
Publicado 2023

Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade

por Möller, Miriam, Turzer, Steffi, Ganchev, Georgi, Wienke, Andreas, Schütte, Wolfgang, Seliger, Barbara, Riemann, Dagmar
Publicado 2022